1. Raviglione MC, Snider DE, Kochi A.Global epidemiology of tuberculosis. JAMA1995; 273:220-226.
2.
2. Brost BC, Newman RB. The maternal and fetal effects of tuberculosis therapy. Obstet Gynecol Clin North Am1997; 24:659-673.
3.
3. McEvoy GK. Antituberculosis agent in: AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists, 1998:438-470.
4.
4. American Thoracic Society and The Centers for Disease Control and Prevention. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med1994; 149:1359-1374.
5.
5. Hamadeh MA, Glassroth J.Tuberculosis and pregnancy. Chest1992; 101:1114-1120.
6.
6. Berlin CM, Lee C.Isoniazid and acetylisoniazid disposition in human milk, saliva and plasma. Fed Proc1079; 38:426-426.
7.
7. Fulton B, Moore LL. Antiinfectives in breastmilk. Part III: Antituberculars, quinolones and urinary germicides. J Hum Lact1993; 9:43-46.
8.
8. Snider DE, Powell KE. Should women taking antituberculosis drugs breast-feed?Arch Intern Med1984; 144:589-590.
9.
9. Knowles JA. Excretion of drugs in milk-A review. J Pediatr1965; 66:1068-1082.
10.
10. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics1994; 93:137-150.
11.
11. American Academy of Pediatrics Committee on Infectious Diseases. Chemotherapy for tuberculosis in infants and children. Pediatrics1992; 89:161-165.
12.
12. Vorherr H.Drug excretion in breast milk. Postgrad Med1974; 56(4):97-104.
13.
13. Simpkins SM, Hench CP, Bhatiqa G.Management of the obstetric patient with tuberculosis. JOGNN1996; 25:305-312.
14.
14. Holdiness MR. Antituberculosis drugs and breast-feeding. Arch Intern Med1984; 144:1888-1888.
15.
15. Chyo N, Sunada H, Nohara S.Clinical studies of kanamycin applied in the field of obstetrics and gynecology. Asian Med J1962; 5:265-275.
16.
16. Morton RF, Mckenna MK, Charles E.Studies on the absorption, diffusion, and excretion of cycloserine. Antibiot Annu1955-1956; 3: 169-172.
